• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于持续递送抗病毒药物的一组可生物降解交联聚酯植入物的表征数据。

Data characterizing a panel of biodegradable cross-linked polyester implants for sustained delivery of an anti-viral drug.

作者信息

Jung Sungmin, Bufton Jack, Bao Zeqing, Cho Wonjoon, Aguiar Dean, Allen Christine

机构信息

Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto M5S 3M2, Canada.

Pendant Inc, JLabs Toronto, 661 University Avenue, Suite 1300, Toronto M5G 0B7, Canada.

出版信息

Data Brief. 2024 Dec 4;58:111182. doi: 10.1016/j.dib.2024.111182. eCollection 2025 Feb.

DOI:10.1016/j.dib.2024.111182
PMID:39802831
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11719335/
Abstract

Tenofovir alafenamide (TAF) is currently administered orally to patients for treatment of chronic hepatitis B virus infection and as a part of a combination therapy for human immunodeficiency virus (HIV) infection. A long-acting delivery system could provide several advantages as a formulation strategy for this drug including improved patient adherence, convenience, more consistent drug levels and potentially fewer side effects. To date, the vast majority of polymer-based long-acting delivery systems have been prepared from poly(lactide--glycolide) [1]. To expand the range of polymers available for use, cross-linkable allyl functionalized, polyester copolymers were considered for preparation of disc-shaped, implantable delivery systems for TAF. The physico-chemical properties of the implants were evaluated including thermal and spectral properties as well as stability. Subsequently the discs were loaded with TAF via a swelling-equilibrium approach and the discs were further characterized including, TAF loading and drug release. This dataset shows the potential of using these polymeric materials as a sustained delivery platform for TAF. The dataset is freely available on Mendeley Data.

摘要

替诺福韦艾拉酚胺(TAF)目前通过口服给药用于治疗慢性乙型肝炎病毒感染,并作为人类免疫缺陷病毒(HIV)感染联合治疗方案的一部分。作为该药物的一种制剂策略,长效给药系统具有诸多优势,包括提高患者依从性、便利性、药物水平更稳定以及潜在的副作用更少。迄今为止,绝大多数基于聚合物的长效给药系统都是由聚(丙交酯-乙交酯)制备的[1]。为了扩大可用聚合物的范围,考虑使用可交联的烯丙基官能化聚酯共聚物来制备用于TAF的盘状可植入给药系统。对植入物的物理化学性质进行了评估,包括热性质、光谱性质以及稳定性。随后通过溶胀平衡法将TAF载入盘中,并对盘进行进一步表征,包括TAF载药量和药物释放情况。该数据集展示了使用这些聚合物材料作为TAF持续给药平台的潜力。该数据集可在Mendeley Data上免费获取。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e544/11719335/70df56aee7ee/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e544/11719335/b21536927179/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e544/11719335/f114fd4d3c1b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e544/11719335/afb26969f94b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e544/11719335/70df56aee7ee/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e544/11719335/b21536927179/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e544/11719335/f114fd4d3c1b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e544/11719335/afb26969f94b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e544/11719335/70df56aee7ee/gr4.jpg

相似文献

1
Data characterizing a panel of biodegradable cross-linked polyester implants for sustained delivery of an anti-viral drug.用于持续递送抗病毒药物的一组可生物降解交联聚酯植入物的表征数据。
Data Brief. 2024 Dec 4;58:111182. doi: 10.1016/j.dib.2024.111182. eCollection 2025 Feb.
2
Fully synthetic injectable depots with high drug content and tunable pharmacokinetics for long-acting drug delivery.高载药量、可调节药代动力学的全合成可注射储库用于长效药物递送。
J Control Release. 2021 Jan 10;329:257-269. doi: 10.1016/j.jconrel.2020.11.030. Epub 2020 Nov 18.
3
Cross-linked valerolactone copolymer implants with tailorable biodegradation, loading and in vitro release of paclitaxel.具有可定制生物降解性、载药量及紫杉醇体外释放特性的交联戊内酯共聚物植入物。
Eur J Pharm Sci. 2021 Jul 1;162:105808. doi: 10.1016/j.ejps.2021.105808. Epub 2021 Mar 15.
4
Performance and Stability of Tenofovir Alafenamide Formulations within Subcutaneous Biodegradable Implants for HIV Pre-Exposure Prophylaxis (PrEP).用于HIV暴露前预防(PrEP)的皮下可生物降解植入剂中替诺福韦艾拉酚胺制剂的性能与稳定性
Pharmaceutics. 2020 Nov 5;12(11):1057. doi: 10.3390/pharmaceutics12111057.
5
Changes in local tissue microenvironment in response to subcutaneous long-acting delivery of tenofovir alafenamide in rats and non-human primates.大鼠和非人灵长类动物中,替诺福韦艾拉酚胺皮下长效给药对局部组织微环境的影响。
J Control Release. 2023 Jun;358:116-127. doi: 10.1016/j.jconrel.2023.04.037. Epub 2023 Apr 29.
6
Characterization of a Reservoir-Style Implant for Sustained Release of Tenofovir Alafenamide (TAF) for HIV Pre-Exposure Prophylaxis (PrEP).用于替诺福韦艾拉酚胺(TAF)持续释放的储库型植入物用于HIV暴露前预防(PrEP)的特性研究。
Pharmaceutics. 2019 Jul 4;11(7):315. doi: 10.3390/pharmaceutics11070315.
7
A Concept Evaluation Study of a New Combination Bictegravir plus Tenofovir Alafenamide Nanoformulation with Prolonged Sustained-Drug-Release Potency for HIV-1 Preexposure Prophylaxis.一种新型组合双替加韦/替诺福韦艾拉酚胺纳米制剂用于 HIV-1 暴露前预防的概念评估研究
Antimicrob Agents Chemother. 2021 Mar 18;65(4). doi: 10.1128/AAC.02320-20.
8
Trans-urocanic acid enhances tenofovir alafenamide stability for long-acting HIV applications.反式尿刊酸增强替诺福韦艾拉酚胺的稳定性,用于长效 HIV 应用。
Int J Pharm. 2020 Sep 25;587:119623. doi: 10.1016/j.ijpharm.2020.119623. Epub 2020 Jul 11.
9
Preclinical Considerations for Long-acting Delivery of Tenofovir Alafenamide from Subdermal Implants for HIV Pre-exposure Prophylaxis.用于 HIV 暴露前预防的替诺福韦艾拉酚胺皮下植入剂长效递药的临床前考量。
Pharm Res. 2023 Jul;40(7):1657-1672. doi: 10.1007/s11095-022-03440-6. Epub 2022 Nov 23.
10
A Tunable, Biodegradable, Thin-Film Polymer Device as a Long-Acting Implant Delivering Tenofovir Alafenamide Fumarate for HIV Pre-exposure Prophylaxis.一种可调节、可生物降解的薄膜聚合物装置,作为长效植入剂用于递送富马酸替诺福韦艾拉酚胺以进行HIV暴露前预防。
Pharm Res. 2016 Jul;33(7):1649-56. doi: 10.1007/s11095-016-1904-6. Epub 2016 Mar 14.

本文引用的文献

1
Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxis.长效替诺福韦艾拉酚胺经皮下植入剂给药用于 HIV 预防的基本问题。
Sci Rep. 2022 May 17;12(1):8224. doi: 10.1038/s41598-022-11020-2.
2
Cross-linked valerolactone copolymer implants with tailorable biodegradation, loading and in vitro release of paclitaxel.具有可定制生物降解性、载药量及紫杉醇体外释放特性的交联戊内酯共聚物植入物。
Eur J Pharm Sci. 2021 Jul 1;162:105808. doi: 10.1016/j.ejps.2021.105808. Epub 2021 Mar 15.
3
Multispecies Evaluation of a Long-Acting Tenofovir Alafenamide Subdermal Implant for HIV Prophylaxis.
用于HIV预防的长效替诺福韦艾拉酚胺皮下植入剂的多物种评估
Front Pharmacol. 2020 Nov 25;11:569373. doi: 10.3389/fphar.2020.569373. eCollection 2020.
4
Clinically established biodegradable long acting injectables: An industry perspective.临床认可的可生物降解长效注射剂:行业视角
Adv Drug Deliv Rev. 2020 Dec;167:19-46. doi: 10.1016/j.addr.2020.11.008. Epub 2020 Nov 14.
5
Performance and Stability of Tenofovir Alafenamide Formulations within Subcutaneous Biodegradable Implants for HIV Pre-Exposure Prophylaxis (PrEP).用于HIV暴露前预防(PrEP)的皮下可生物降解植入剂中替诺福韦艾拉酚胺制剂的性能与稳定性
Pharmaceutics. 2020 Nov 5;12(11):1057. doi: 10.3390/pharmaceutics12111057.
6
A Subcutaneous Implant of Tenofovir Alafenamide Fumarate Causes Local Inflammation and Tissue Necrosis in Rabbits and Macaques.富马酸替诺福韦艾拉酚胺的皮下植入物可引起兔和猕猴的局部炎症和组织坏死。
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.01893-19.
7
Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIV.在开发长效注射剂以预防和治疗 HIV 的同时,应对全球乙型肝炎病毒负担。
Lancet HIV. 2020 Jun;7(6):e443-e448. doi: 10.1016/S2352-3018(19)30342-X. Epub 2019 Dec 20.
8
Characterization of a Reservoir-Style Implant for Sustained Release of Tenofovir Alafenamide (TAF) for HIV Pre-Exposure Prophylaxis (PrEP).用于替诺福韦艾拉酚胺(TAF)持续释放的储库型植入物用于HIV暴露前预防(PrEP)的特性研究。
Pharmaceutics. 2019 Jul 4;11(7):315. doi: 10.3390/pharmaceutics11070315.
9
Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis.经皮可再填充纳米流控植入物实现了替诺福韦二磷酸酯的持续水平,用于 HIV 暴露前预防。
J Control Release. 2018 Sep 28;286:315-325. doi: 10.1016/j.jconrel.2018.08.010. Epub 2018 Aug 6.